Article Text
Extended Report
Low circulating soluble interleukin-2 receptor level predicts rapid response in patients with refractory rheumatoid arthritis treated with infliximab
Statistics from Altmetric.com
This is a PDF-only article. The first page of the PDF of this article appears above.